Concepedia

Author

M. Liersch

Novartis (Switzerland)

Also Known As

M Liersch, M. Liersch, Manfred Liersch

22

Publications

288

Citations

7

H-Index

32

Concepts

All Affiliations

Novartis (Switzerland)
ML

About

M. Liersch is an author at Novartis (Switzerland) specializing in medicine, biochemistry, and bioanalysis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

242

2

Biochemistry

5

5

185

3

Natural Sciences

3

3

49

4

Engineering

2

2

136

5

Biomolecular Engineering

1

1

39

M. Liersch

×

6

Publications

242

Citations

6

H-Index

YearCitations

A large fragment approach to DNA synthesis: total synthesis of a gene for the protease inhibitor eglin c from the leech<i>Hirudo medicinalis</i>and its expression in<i>E. coli</i>

H Rink, M. Liersch, Peter Sieber,

Nucleic Acids Research

1984

97

Determination of specific growth stages of plant cell suspension cultures by monitoring conductivity changes in the medium

Klaus Hahlbrock, J�rgen Ebel, Ann Oaks,

Planta

1974

57

Sequence determination of eglin c using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation

René Knecht, U Seemüller, M. Liersch,

Analytical Biochemistry

1983

39

Eglin c, a pharmacologically active elastase inhibitor.

Schnebli Hp, U Seemüller, Hans Fritz,

PubMed

1985

20

Methionine Metabolism and Cephalosporin C Synthesis in <i>Cephalosporium acremonium</i><scp>d</scp>‐Amino Acid Oxidase

F. Benz, M. Liersch, J. Nüuesch,

European Journal of Biochemistry

1971

18

Isolation and characterization of recombinant desulfatohirudin from yeast, a highly selective thrombin inhibitor

H. Grossenbacher, J. A. L. Auden, Kurt Bill,

Thrombosis Research

1987

11

Page 1